0

POC Molecular Diagnostics Market by Product, Application, and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 158
  • SKU: IRTNTR45390
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

According to Technavio analysts, the POC molecular diagnostics market share is expected to increase by USD 1.83 billion from 2021 to 2026 at an accelerating CAGR of 14.67%. The report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.

The POC molecular diagnostics market research report extensively covers POC molecular diagnostics market segmentation by product (PCR and microarray and hybridization), application (infectious diseases, oncology, hematology and endocrinology, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)).

The POC molecular diagnostics market vendors studied and compiled in this report include Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. among others.

What will the POC Molecular Diagnostics Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the POC Molecular Diagnostics Market Size for the Forecast Period and Other Important Statistics

 

POC Molecular Diagnostics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The growing geriatric population is notably driving the POC molecular diagnostics market growth, although factors such as strained laboratory budgets and lowering reimbursements affecting instrument sales may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the POC molecular diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key POC Molecular Diagnostics Market Driver

  • One of the key factors driving the global POC molecular diagnostics industry growth is the growing geriatric population.
  • The absence of physical activity and improper diet in today's lifestyle has led to major medical problems, especially in the geriatric population.
  • The geriatric population is increasing significantly across the world.
    • For instance, in 2020 the growth rate of the geriatric population in Australia was 16% and 20% in France.  
  • The prevalence of diseases such as lung disease, cancer, and stroke, is high among the aging population.
  • Apart from the impaired functioning of the immune system, the reduced functioning of organs also increases the chances of acquiring infections.
  • The elderly require diagnostic testing regularly due to their low immunity and metabolism.
  • These factors have increased the demand for POC molecular diagnostics, as these instruments assist in disease diagnosis, which will be contributing to market growth.

Key POC Molecular Diagnostics Market Trend

  • Growing focus on technological advances is one of the key POC molecular diagnostics market trends that is expected to impact the industry positively in the forecast period.
  • To increase the efficiency and effectiveness of the results, the companies are developing advanced products.
    • QuantuMDx Group offers Q-POC. This Q-POC is a portable device that provides results within 20 minutes.
    • RANDOX BIOSCIENCES has come up with Familial Hypercholesterolemia (FH) Arrays I and II, which are rapid, simple, and accurate diagnostics test for the detection of 40 FH-causing mutations (20 mutations per array) within the LDLR, ApoB, and PCSK9 genes. These assays are based on the combination of multiplex PCR and biochip array hybridization.
  • Therefore, the burden of extra cost to the end-users in the form of additional tests is reduced along with the ease of detection. 

Key POC Molecular Diagnostics Market Challenge

  • One of the key challenges to the global POC molecular diagnostics industry growth is the strained laboratory budgets and lowering reimbursements affecting instrument sales.
  • The reimbursement policies for diagnostic testing are not constant across various geographies, and they are moving in a downward trend.
  • Hospitals and diagnostic laboratories are reducing their expenditure on POC molecular diagnostics to have either break even or profitable revenue. These factors have led clinical laboratories to find alternative ways to maintain revenue despite limited capacity and testing volumes.
    • Lean laboratories are observed in some countries, which limit new capital equipment purchases to only those essentially required or provide an immediate return on investment.
  • The US has similar situations for POC molecular diagnostics, and a reduction of reimbursement by Medicare may limit the demand for certain diagnostic testing across all segments. This has, in turn, affected the sales of new instruments for POC molecular diagnostics testing, which may limit the market growth in the coming years.

This POC molecular diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global POC molecular diagnostics market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the POC molecular diagnostics market during the forecast period.

Who are the Major POC Molecular Diagnostics Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • binx Health Inc.
  • Co-Diagnostics Inc.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • genedrive plc
  • Lucira Health Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • OraSure Technologies Inc.
  • QIAGEN NV
  • QuantuMDx Group Ltd.
  • Randox Laboratories Ltd.
  • Robert Bosch GmbH
  • Siemens AG
  • Sysmex Corp.
  • Talis Biomedical Corp.
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA
  • Quidel Corp.

 

This statistical study of the POC molecular diagnostics market encompasses successful business strategies deployed by the key vendors. The POC molecular diagnostics market is fragmented and the vendors are deploying growth strategies such as technological innovation to compete in the market.

Product Insights and News

  • Abbott Laboratories - The company offers a portable, rapid molecular ID NOW COVID-19 test that allows fast diagnosis with results in 13 minutes or less in a variety of locations such as point-of-care locations.
  • Abbott Laboratories - Under the established pharmaceuticals products segment, the company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The POC molecular diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

POC Molecular Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the POC molecular diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for POC Molecular Diagnostics Market?

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for POC molecular diagnostics in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The increasing prevalence of chronic diseases, rising demand for robust systems for continuous real-time patient monitoring, continuous technological advances, presence of developed healthcare infrastructure, increasing healthcare expenditure, and the strong presence of key vendors will facilitate the POC molecular diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

There has been a positive impact on the market growth during and post COVID-19 era. Pharmaceutical companies in North America have been prioritizing research and development of COVID-19-related treatments, health technologies, and vaccines and looking at the potential of using existing treatments.

  • For instance, in 2020, AbbVie partnered with global authorities to determine the effectiveness of HIV drugs in the treatment of COVID-19.

Such initiatives will further support the growth of the regional POC molecular diagnostics market during the forecast period 

What are the Revenue-generating Product Segments in the POC Molecular Diagnostics Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The POC molecular diagnostics market share growth by the PCR segment will be significant during the forecast period. PCR can help in detecting or identifying infectious and chronic ailments. The increasing global prevalence of target diseases, as well as the shown usefulness of PCR analysis in the diagnosis and estimation of disease-causing bacteria, will drive demand for clinical diagnostic tests and drive market growth.

This report provides an accurate prediction of the contribution of all the segments to the growth of the POC molecular diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

 

POC Molecular Diagnostics Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 14.67%

Market growth 2022-2026

$ 1.83 billion

Market structure

Fragmented

YoY growth (%)

10.4

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key consumer countries

US, Canada, Germany, France, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this POC Molecular Diagnostics Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive POC molecular diagnostics market growth during the next five years
  • Precise estimation of the POC molecular diagnostics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the POC molecular diagnostics industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of POC molecular diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 18: Five forces analysis - Comparison between2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 25: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 26: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 27: Chart on Comparison by Product
      • Exhibit 28: Data Table on Comparison by Product
    • 5.3 PCR - Market size and forecast 2021-2026
      • Exhibit 29: Chart on PCR - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Data Table on PCR - Market size and forecast 2021-2026 ($ million)
      • Exhibit 31: Chart on PCR - Year-over-year growth 2021-2026 (%)
      • Exhibit 32: Data Table on PCR - Year-over-year growth 2021-2026 (%)
    • 5.4 Microarray and hybridization - Market size and forecast 2021-2026
      • Exhibit 33: Chart on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Data Table on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
      • Exhibit 35: Chart on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
      • Exhibit 36: Data Table on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Product
      • Exhibit 37: Market opportunity by Product ($ million)

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 38: Chart on Application - Market share 2021-2026 (%)
      • Exhibit 39: Data Table on Application - Market share 2021-2026 (%)
    • 6.2 Comparison by Application
      • Exhibit 40: Chart on Comparison by Application
      • Exhibit 41: Data Table on Comparison by Application
    • 6.3 Infectious diseases - Market size and forecast 2021-2026
      • Exhibit 42: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
    • 6.4 Oncology - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Oncology - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
    • 6.5 Hematology and endocrinology - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
    • 6.6 Others - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 6.7 Market opportunity by Application
      • Exhibit 58: Market opportunity by Application ($ million)

    7 Customer Landscape

    • 7.1 Customer landscape overview
      • Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    8 Geographic Landscape

    • 8.1 Geographic segmentation
      • Exhibit 60: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 61: Data Table on Market share by geography 2021-2026 (%)
    • 8.2 Geographic comparison
      • Exhibit 62: Chart on Geographic comparison
      • Exhibit 63: Data Table on Geographic comparison
    • 8.3 North America - Market size and forecast 2021-2026
      • Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 8.4 Europe - Market size and forecast 2021-2026
      • Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 8.5 Asia - Market size and forecast 2021-2026
      • Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 8.7 US - Market size and forecast 2021-2026
      • Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 8.8 Germany - Market size and forecast 2021-2026
      • Exhibit 84: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 85: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 86: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 87: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 8.9 Canada - Market size and forecast 2021-2026
      • Exhibit 88: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 89: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 90: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 91: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 8.10 China - Market size and forecast 2021-2026
      • Exhibit 92: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 93: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 94: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 95: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 8.11 France - Market size and forecast 2021-2026
      • Exhibit 96: Chart on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 97: Data Table on France - Market size and forecast 2021-2026 ($ million)
      • Exhibit 98: Chart on France - Year-over-year growth 2021-2026 (%)
      • Exhibit 99: Data Table on France - Year-over-year growth 2021-2026 (%)
    • 8.12 Market opportunity by geography
      • Exhibit 100: Market opportunity by geography ($ million)

    9 Drivers, Challenges, and Trends

    • 9.1 Market drivers
      • 9.2 Market challenges
        • 9.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2021 and 2026
        • 9.4 Market trends

          10 Vendor Landscape

          • 10.1 Overview
            • 10.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 10.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 10.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            11 Vendor Analysis

            • 11.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 11.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 11.3 Abbott Laboratories
              • Exhibit 107: Abbott Laboratories - Overview
              • Exhibit 108: Abbott Laboratories - Business segments
              • Exhibit 109: Abbott Laboratories - Key news
              • Exhibit 110: Abbott Laboratories - Key offerings
              • Exhibit 111: Abbott Laboratories - Segment focus
            • 11.4 bioMerieux SA
              • Exhibit 112: bioMerieux SA - Overview
              • Exhibit 113: bioMerieux SA - Business segments
              • Exhibit 114: bioMerieux SA - Key offerings
              • Exhibit 115: bioMerieux SA - Segment focus
            • 11.5 Danaher Corp.
              • Exhibit 116: Danaher Corp. - Overview
              • Exhibit 117: Danaher Corp. - Business segments
              • Exhibit 118: Danaher Corp. - Key news
              • Exhibit 119: Danaher Corp. - Key offerings
              • Exhibit 120: Danaher Corp. - Segment focus
            • 11.6 F. Hoffmann La Roche Ltd.
              • Exhibit 121: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 122: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 123: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus
            • 11.7 QIAGEN NV
              • Exhibit 126: QIAGEN NV - Overview
              • Exhibit 127: QIAGEN NV - Product / Service
              • Exhibit 128: QIAGEN NV - Key news
              • Exhibit 129: QIAGEN NV - Key offerings
            • 11.8 QuantuMDx Group Ltd.
              • Exhibit 130: QuantuMDx Group Ltd. - Overview
              • Exhibit 131: QuantuMDx Group Ltd. - Product / Service
              • Exhibit 132: QuantuMDx Group Ltd. - Key offerings
            • 11.9 Quidel Corp.
              • Exhibit 133: Quidel Corp. - Overview
              • Exhibit 134: Quidel Corp. - Product / Service
              • Exhibit 135: Quidel Corp. - Key offerings
            • 11.10 Robert Bosch GmbH
              • Exhibit 136: Robert Bosch GmbH - Overview
              • Exhibit 137: Robert Bosch GmbH - Business segments
              • Exhibit 138: Robert Bosch GmbH - Key news
              • Exhibit 139: Robert Bosch GmbH - Key offerings
              • Exhibit 140: Robert Bosch GmbH - Segment focus
            • 11.11 Siemens AG
              • Exhibit 141: Siemens AG - Overview
              • Exhibit 142: Siemens AG - Business segments
              • Exhibit 143: Siemens AG - Key news
              • Exhibit 144: Siemens AG - Key offerings
              • Exhibit 145: Siemens AG - Segment focus
            • 11.12 Thermo Fisher Scientific Inc.
              • Exhibit 146: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 147: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 148: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 149: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 150: Thermo Fisher Scientific Inc. - Segment focus

            12 Appendix

            • 12.1 Scope of the report
              • 12.2 Inclusions and exclusions checklist
                • Exhibit 151: Inclusions checklist
                • Exhibit 152: Exclusions checklist
              • 12.3 Currency conversion rates for US$
                • Exhibit 153: Currency conversion rates for US$
              • 12.4 Research methodology
                • Exhibit 154: Research methodology
                • Exhibit 155: Validation techniques employed for market sizing
                • Exhibit 156: Information sources
              • 12.5 List of abbreviations
                • Exhibit 157: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The poc molecular diagnostics market growth will increase by $1838.2 million during 2022-2026.
              The poc molecular diagnostics market is expected to grow at a CAGR of 14.67% during 2022-2026.
              Technavio has segmented the poc molecular diagnostics market by product (PCR and Microarray and hybridization) ,application (Infectious diseases, Oncology, Hematology and endocrinology, and Others) , and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, Quidel Corp. are a few of the key vendors in the poc molecular diagnostics market.
              North America will register the highest growth rate of 44.25% among the other regions. Therefore, the poc molecular diagnostics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the poc molecular diagnostics market growth are:
              • Growing geriatric population
              • Growing focus on technological advances
              The poc molecular diagnostics market vendors should focus on grabbing business opportunities from the pcr segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>